Preview Mode Links will not work in preview mode

This Week in Cardiology

Feb 26, 2021

Risk factors for COVID-19, CMR after COVID-19, and two important obesity studies are discussed in this week’s podcast. To read a partial transcript or to comment

Cardiometabolic Conditions and COVID19

Most Severe COVID Tied to Four Cardiometabolic Conditions

Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis

CMR after COVID19

Myocardial Injury Seen on MRI in 54% of Recovered COVID

Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance

Obesity Trials

Semaglutide for Weight Loss? A Good First STEP, With Caveats

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Major Breakthrough in Weight Loss With Semaglutide?

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity


Fired for Good Judgment a Sign of Physicians' Lost Respect

A Tribute to Bernard Lown

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact